Similar articles

• Adverse effects of isotretinoin: A retrospective review of 1743 patients started on isotretinoin.

  Rademaker M. Rademaker M. Australas J Dermatol. 2010 Nov;51(4):248-53. doi: 10.1111/j.1440-0960.2010.00657.x. Australas J Dermatol. 2010. PMID: 21198520
• Isotretinoin therapy and the incidence of acne relapse: a nested case-control study.

  Layton AM, Dréno B, Gollnick H, Mobaken H, Shear N. Layton AM, et al. Br J Dermatol. 2009 Jan;160(1):217-8; author reply 218-9. doi: 10.1111/j.1365-2133.2008.08935.x. Epub 2008 Nov 29. Br J Dermatol. 2009. PMID: 19067687 No abstract available.
• Acute acne flare following isotretinoin administration: potential protective role of low starting dose.

  Borghi A, Mantovani L, Minghetti S, Virgili A, Bettoli V. Borghi A, et al. Dermatology. 2009;218(2):178-80. doi: 10.1159/000182270. Epub 2008 Dec 5. Dermatology. 2009. PMID: 19060474 No abstract available.
• The role of isotretinoin in acne therapy: why not as first-line therapy? facts and controversies.

  Rigopoulos D, Larios G, Katsambas AD. Rigopoulos D, et al. Clin Dermatol. 2010 Jan-Feb;28(1):24-30. doi: 10.1016/j.clindermatol.2009.03.005. Clin Dermatol. 2010. PMID: 20082946 Review.
• Isotretinoin dosing: past, present, and future trends.

  Hirsch RJ, Shalita AR. Hirsch RJ, et al. Semin Cutan Med Surg. 2001 Sep;20(3):162-5. doi: 10.1053/sder.2001.27551. Semin Cutan Med Surg. 2001. PMID: 11594671 Review.